[Video] Delayed pharmaceutical tracing requirements take effect

by Laura Johnson, on March 16, 2016

Screen_Shot_2016-03-14_at_9.11.19_AMBeginning on March 1, a delayed provision of the Drug Supply Chain Security Act will finally go into effect. Pharmaceutical dispensers will be required to conduct lot-level product tracing, which includes keeping detailed records of a drug's transaction history.

The purpose of this provision is to improve the traceability of prescription drugs within the U.S. and protect users from any problems that may originate within the supply chain. This will contribute to the national electronic system that the DSCSA will have established by 2023.

 Enterprise labeling can replace error-prone manual labeling options, ensuring consistency and accuracy while meeting the demands of this unfolding regulation.

Thanks for watching, and check back later for more on how enterprise labeling is vital for improving pharmaceutical traceability. For more information on pharma labeling and DSCSA requirements, download the on demand webinar below with Ferring Pharmaceuticals.

 Download Ferring Pharma Webinar Today!